1-deoxynojirimycin has been researched along with Lysosomal Enzyme Disorders, Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champion, H; Cox, TM; Gallagher, J; Imrie, J; Lachmann, RH; Ramaswami, U; Wraith, JE | 1 |
| Itoh, K; Tsuji, D | 1 |
1 review(s) available for 1-deoxynojirimycin and Lysosomal Enzyme Disorders, Nervous System
| Article | Year |
|---|---|
[Molecular pathogenesis and therapeutic targets of lysosomal diseases].
Topics: 1-Deoxynojirimycin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta-N-Acetylhexosaminidases; Bone Marrow Transplantation; Disease Models, Animal; G(M2) Activator Protein; Genetic Therapy; Humans; Lysosomal Storage Diseases, Nervous System; Mutation | 2007 |
1 other study(ies) available for 1-deoxynojirimycin and Lysosomal Enzyme Disorders, Nervous System
| Article | Year |
|---|---|
Dietary modifications in patients receiving miglustat.
Topics: 1-Deoxynojirimycin; Adolescent; Adolescent Development; Adult; Age Factors; Child; Child Development; Diet, Carbohydrate-Restricted; England; Enzyme Inhibitors; Gastrointestinal Diseases; Glucosyltransferases; Humans; Lactose; Lysosomal Storage Diseases, Nervous System; Retrospective Studies; Time Factors; Treatment Outcome; Weight Loss; Young Adult | 2010 |